pubmed.ncbi.nlm.nih.gov

Neurotoxins: Current Concepts in Cosmetic Use on the Face and Neck--Lower Face - PubMed

Review

Neurotoxins: Current Concepts in Cosmetic Use on the Face and Neck--Lower Face

Douglas C Wu et al. Plast Reconstr Surg. 2015 Nov.

Abstract

Botulinum toxin A was Food and Drug Administration approved in 2002 for the temporary correction of glabellar frown lines. Since that time, a variety of neuromodulators have established a convincing profile for both safety and efficacy in the treatment hyperdynamic rhytides of the upper face. With increasing clinical experience and expertise, these applications have been expanded to include targeted treatment of muscles in both the mid and lower face. This article details common techniques using botulinum toxin to treat orbicularis oris, depressor anguli oris, mentalis, and masseter muscles for the temporary correction of unwanted lower face hyperdynamic rhytides and facial contouring. Although we detail our suggested quantity of units per injection site based on onabotulinumtoxinA, all neuromodulators can be used in all of these suggested treatment areas with adjustment of the quantity of units based on the efficacy of the specific neuromodulator. A more compete discussion on the relative efficacy of all neuromodulators is beyond the scope of this article.

PubMed Disclaimer

Cited by

Neurophysiological Measures of Efficacy and Safety for Botulinum Toxin Injection in Facial and Bulbar Muscles: Special Considerations.
Alimohammadi M, Punga AR. Alimohammadi M, et al. Toxins (Basel). 2017 Oct 30;9(11):352. doi: 10.3390/toxins9110352. Toxins (Basel). 2017. PMID: 29084148 Free PMC article. Review.
Use of botulinum toxin in aesthetic medicine and gynaecology: current approaches, controversies, and future directions.
Etrusco A, Geru M, Laganà AS, Chiantera V, Giannini A, Buzzaccarini G. Etrusco A, et al. Prz Menopauzalny. 2023 Sep;22(3):155-160. doi: 10.5114/pm.2023.131457. Epub 2023 Sep 25. Prz Menopauzalny. 2023. PMID: 37829261 Free PMC article. Review.
Botulinum Toxin Application in Facial Esthetics and Recent Treatment Indications (2013-2018).
Kattimani V, Tiwari RVC, Gufran K, Wasan B, Shilpa PH, Khader AA. Kattimani V, et al. J Int Soc Prev Community Dent. 2019 Mar-Apr;9(2):99-105. doi: 10.4103/jispcd.JISPCD_430_18. Epub 2019 Apr 12. J Int Soc Prev Community Dent. 2019. PMID: 31058058 Free PMC article. Review.

References

1. Semchyshyn N, Sengelmann RD. Botulinum toxin A treatment of perioral rhytides. Dermatol Surg. 2003;29:490–495
1. Cohen JL, Dayan SH, Cox SE, et al. OnabotulinumtoxinA dose-ranging study for hyperdynamic perioral lines. Dermatol Surg. 2012;38:1497–1505
1. Choi YJ, Kim JS, Gil YC, et al. Anatomical considerations regarding the location and boundary of the depressor anguli oris muscle with reference to botulinum toxin injection. Plast Reconstr Surg. 2014;134:917–921
1. Carruthers J, Carruthers A. Aesthetic botulinum A toxin in the mid and lower face and neck. Dermatol Surg. 2003;29:468–476
1. Hur MS, Kim HJ, Choi BY, et al. Morphology of the mentalis muscle and its relationship with the orbicularis oris and incisivus labii inferioris muscles. J Craniofac Surg. 2013;24:602–604

Neurotoxins: Current Concepts in Cosmetic Use on the Face and Neck--Lower Face - PubMed